Madison Elsaadi Profile - B. Riley Securities Analyst
256 Followers
Madison Elsaadi's Stock Coverage
| CAPRCapricor Therapeutics | Nov 11, 2026 | BUY | Reiterated | $21.00 | 9Ratings | -10.25% | ||
| SPRBSpruce Biosciences | Nov 10, 2026 | BUY | Reiterated | $160.00 | 2Ratings | -2.70% | ||
| ETONEton Pharmaceuticals | Nov 10, 2026 | BUY | Reiterated | $81.00 | 15Ratings | +104.33% | ||
| ARWRArrowhead Pharmaceuticals | Nov 10, 2026 | BUY | Reiterated | $123.00 | 8Ratings | +51.87% | ||
| WVEWave Life Sciences | Nov 09, 2026 | BUY | Reiterated | $18.00 | 18Ratings | -19.08% | ||
| STIMNeuronetics | Nov 06, 2026 | BUY | Initiated | $6.00 | 2Ratings | -24.60% | ||
| VNDAVanda | Oct 29, 2026 | BUY | Reiterated | $12.00 | 7Ratings | -23.98% | ||
| OBIOOrchestra BioMed Holdings | Oct 02, 2026 | BUY | Reiterated | $11.00 | 2Ratings | +0.30% | ||
| ANIKAnika Therapeutics | Sep 18, 2026 | BUY | Initiated | $23.00 | 1Ratings | -32.90% | ||
| CMPSCOMPASS Pathways | Aug 06, 2026 | BUY | Reiterated | $22.00 | 2Ratings | -17.10% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Madison Elsaadi activity FAQ
What is the performance of Madison Elsaadi's recommendations?
The percentage of profitable recommendations made by Madison Elsaadi is 47.46%, and the average return per transaction is 29.10%.
What stocks does Madison Elsaadi cover?
Madison Elsaadi mostly covers Capricor Therapeutics, Arrowhead Pharmaceuticals, Eton Pharmaceuticals stocks.
What was Madison Elsaadi's most profitable rating?
Madison Elsaadi’s most profitable rating was a buy on Arrowhead Pharmaceuticals stock on Aug 11, 2025. The return on the trade was 418.50%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here